TY - JOUR
T1 - Telomere dysfunction activates YAP1 to drive tissue inflammation
AU - Chakravarti, Deepavali
AU - Hu, Baoli
AU - Mao, Xizeng
AU - Rashid, Asif
AU - Li, Jiexi
AU - Li, Jun
AU - Liao, Wen-Ting
AU - Whitley, Elizabeth M
AU - Dey, Prasenjit
AU - Hou, Pingping
AU - LaBella, Kyle A
AU - Chang, Andrew
AU - Wang, Guocan
AU - Spring, Denise J
AU - Deng, Pingna
AU - Zhao, Di
AU - Liang, Xin
AU - Lan, Zhengdao
AU - Lin, Yiyun
AU - Sarkar, Sharmistha
AU - Terranova, Christopher
AU - Deribe, Yonathan Lissanu
AU - Blutt, Sarah E
AU - Okhuysen, Pablo
AU - Zhang, Jianhua
AU - Vilar, Eduardo
AU - Nielsen, Ole Haagen
AU - Dupont, Andrew
AU - Younes, Mamoun
AU - Patel, Kalyani R
AU - Shroyer, Noah F
AU - Rai, Kunal
AU - Estes, Mary K
AU - Wang, Y Alan
AU - Bertuch, Alison A
AU - DePinho, Ronald A
PY - 2020/9/21
Y1 - 2020/9/21
N2 - Germline telomere maintenance defects are associated with an increased incidence of inflammatory diseases in humans, yet whether and how telomere dysfunction causes inflammation are not known. Here, we show that telomere dysfunction drives pATM/c-ABL-mediated activation of the YAP1 transcription factor, up-regulating the major pro-inflammatory factor, pro-IL-18. The colonic microbiome stimulates cytosolic receptors activating caspase-1 which cleaves pro-IL-18 into mature IL-18, leading to recruitment of interferon (IFN)-γ-secreting T cells and intestinal inflammation. Correspondingly, patients with germline telomere maintenance defects exhibit DNA damage (γH2AX) signaling together with elevated YAP1 and IL-18 expression. In mice with telomere dysfunction, telomerase reactivation in the intestinal epithelium or pharmacological inhibition of ATM, YAP1, or caspase-1 as well as antibiotic treatment, dramatically reduces IL-18 and intestinal inflammation. Thus, telomere dysfunction-induced activation of the ATM-YAP1-pro-IL-18 pathway in epithelium is a key instigator of tissue inflammation.
AB - Germline telomere maintenance defects are associated with an increased incidence of inflammatory diseases in humans, yet whether and how telomere dysfunction causes inflammation are not known. Here, we show that telomere dysfunction drives pATM/c-ABL-mediated activation of the YAP1 transcription factor, up-regulating the major pro-inflammatory factor, pro-IL-18. The colonic microbiome stimulates cytosolic receptors activating caspase-1 which cleaves pro-IL-18 into mature IL-18, leading to recruitment of interferon (IFN)-γ-secreting T cells and intestinal inflammation. Correspondingly, patients with germline telomere maintenance defects exhibit DNA damage (γH2AX) signaling together with elevated YAP1 and IL-18 expression. In mice with telomere dysfunction, telomerase reactivation in the intestinal epithelium or pharmacological inhibition of ATM, YAP1, or caspase-1 as well as antibiotic treatment, dramatically reduces IL-18 and intestinal inflammation. Thus, telomere dysfunction-induced activation of the ATM-YAP1-pro-IL-18 pathway in epithelium is a key instigator of tissue inflammation.
KW - Adaptor Proteins, Signal Transducing/antagonists & inhibitors
KW - Animals
KW - Anti-Bacterial Agents/therapeutic use
KW - Ataxia Telangiectasia Mutated Proteins/antagonists & inhibitors
KW - Caspase 1/metabolism
KW - Cell Cycle Proteins/antagonists & inhibitors
KW - Child
KW - Colon/metabolism
KW - Gastrointestinal Diseases/pathology
KW - Gastrointestinal Microbiome/drug effects
KW - Humans
KW - Inflammation/drug therapy
KW - Interleukin-18/genetics
KW - Intestinal Mucosa/metabolism
KW - Mice
KW - Mice, Mutant Strains
KW - Phosphorylation
KW - Protein Precursors/genetics
KW - Signal Transduction
KW - Telomerase/genetics
KW - Telomere/pathology
U2 - 10.1038/s41467-020-18420-w
DO - 10.1038/s41467-020-18420-w
M3 - Journal article
C2 - 32958778
SN - 2041-1722
VL - 11
SP - 4766
JO - Nature Communications
JF - Nature Communications
IS - 1
ER -